Catalyst Wire Dossier Catalyst Wire Dossier

AAV2-BDNF gene therapy

AAV2-BDNF gene therapy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAV2-BDNF gene therapy, covering 2025-10-21 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment [Phase 1]

See pricing